logo

Fennec Pharmaceuticals Inc (FENC)



Trade FENC now with
  Date
  Headline
4/27/2022 6:46:07 AM Fennec Pharma Announces FDA Acceptance For Filing Of NDA Resubmission For PEDMARK
3/24/2022 4:24:27 PM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $10 Price Target
3/24/2022 6:17:04 AM Fennec Pharma Resubmits NDA For Pedmark
2/28/2022 4:56:02 PM Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) FY22 Estimate To -0.54 From -0.51
2/28/2022 4:55:47 PM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 22 Estimate To -0.14 From -0.13
2/28/2022 4:55:37 PM Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q1 22 Estimate To -0.14 From -0.12
2/28/2022 4:55:10 PM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $10 Up From $9 Price Target
1/31/2022 6:19:15 AM Fennec Pharma's Chief Commercial Officer Shubh Goel To Depart In Late February
11/30/2021 6:06:52 AM Fennec Pharma Receives CRL From FDA For PEDMARK NDA Again
11/29/2021 6:24:08 AM Fennec Pharma Expects To Receive CRL From FDA For PEDMARK NDA
11/10/2021 6:05:25 AM Fennec Pharma Q3 Loss Per Share $0.16 Vs Loss $0.24 Last Year
8/10/2021 6:12:12 AM Fennec Pharma Q2 Net Loss $4.0 Mln Or $0.15/Shr Vs Loss $4.8 Mln Or $0.21/Shr Last Year
6/24/2021 6:12:33 AM Fennec Pharma Amends Existing Senior Debt Facility With Life Sciences At Bridge Bank Increasing The Size To $20 Mln
6/22/2021 6:31:52 AM Fennec Pharma: FDA Accepts Filing The Resubmission Of NDA For PEDMARK
5/10/2019 8:39:36 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY19 Estimate To -0.61 From 2.74